Improved formulations, compatibility, and awareness throughout the value chain drive higher adoption even as the segment battles through supply chain issues.
Biological market is already on the rebound from pandemic-related slowdown, with years of growth ahead.
The row crop biopesticide market remains on the front end of its infancy stage, although new and evolving […]
If you’re an ag retailer and you’re reading this report, I’d guess it’s fair to assume you’ve at […]
Richard Rominger, former Deputy Secretary of the USDA and former agricultural secretary of California, emceed a 10th anniversary luncheon […]
Arysta LifeScience recently signed a licensing agreement with the Institute of Plant Protection (IPP) granting Arysta LifeScience exclusive […]
This often overlooked niche hopes to find new fans in the coming years.
Biopesticides are a suddenly hot topic at every level of the value chain. Why? Find out in this […]
There’s an old bit of wisdom regarding cooperation and friendship that says that two heads are better than […]
The company sets its sights on the American agriculture landscape, introducing cutting-edge sustainable farming solutions.
Experts expect big things for biologicals in row crops — once the product choices are perfected.
Crop Science Division will capitalize on opportunities presented by the shift to regenerative ag to grow in adjacent markets, in addition to its core business.
The technology’s initial priority crop pest target is the Colorado potato beetle.
With registration now open, delegates can secure their spot and take advantage of this exceptional opportunity to connect with the leading minds in agribusiness.
Science, efficacy, and formulation improvement — along with consumer and regulatory forces — converge to help the biopesticides market continue growing.
With its present looking solid, the future for the biologicals category appears much brighter than it did at the start of the 2020s.
According to this year’s biological survey, the category has slowed down somewhat in growth, even as more companies (and products) enter the marketplace.
Acquisition strengthens Valent BioSciences’ participation in the rapidly growing $3.5 billion global biostimulant market.
Team dedicated to AMVAC’s biological portfolio, which consists of biopesticides, biostimulants, and biofertilizers.
One expert at Helena Agri-Enterprises foresees how the biologicals movement in the U.S. might progress going forward.